Anti-aging, sun damage propel prescription derm sector.
The findings come from the tenth edition of the company's Prescription Dermatological Drugs report.
"This is an exciting time in dermatology as there continues to be a shift in the understanding of the pathophysiology of many skin diseases," said Mary Ann Crandall. "And there's new biologics and their uses in dermatology."
Crandall also said there are new trends such as a movement toward dispensing prescription dermatology agents in the office.
Another interesting area is the growth in the demand for platelet rich plasma. When PRP is injected into the damaged area, it stimulates the tissue, causing mild inflammation that triggers a healing cascade. This area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers (both men and women) for antiaging products, consolidation within the industry and strong late stage pipeline entities, said Kalorama.
The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded.
According to Kalorama, while there are a number of companies participating in the worldwide market for prescription dermatological drugs--ranging from large international pharmaceutical companies, small niche pharmaceutical companies to generic companies both large and small--there is also competitive pressure from over-the-counter (OTC) participants. However, even with the availability of OTC products, manufacturers of prescription products continue to do well in terms of revenues. Demand for products in the prescription dermatological market will likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby boomers. Competitors are increasingly offering products that meet this need, which is an entirely different concept than other products that the companies may offer.
Consumer Wipes Market To Hit $1.9 Billion in 2021
* Consumer wipes accounted for 56% of overall wipes sales in 2016, and demand for consumer wipes is expected to increase 2.5% a year to $1.9 billion in 2021, according to a report from The Freedonia Group.
More than 80% of consumer wipes sales in 2016 were for personal care wipes, with baby wipes accounting for the majority of personal care wipes sales. However, given the maturity of the baby wipes market, the fastest growth among consumer wipes will be tied to sales of household care and other consumer wipes.
These and other trends are presented in Wipes Market in the US, 8th Edition, a new study from The Freedonia Group, a Cleveland-based industry research firm.
In household care wipes, 32% of sales are tied to dry wipes, primarily due to the floor care segment. In this application, wipes are often used to lift away light soils such as dust and small amounts of dirt without the help of a solvent or surfactant. This is often due to an electrostatic charge that can attract and hold dust and other small particles.
There are significant differences in the market shares of the several segments of the personal care wipes market, depending on whether share is measured in value or in volume terms. By volume, baby wipes accounted for about 82% of personal care wipes in 2016, while in value terms they accounted for only 67% of the segment.
More info: www.freedoniagroup.com
Happi's sixth Anti-Aging Conference & Tabletop Exhibition will be held Nov. 29-30, 2017 in New Brunswick, NJ.
More info: conference.happi.com
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||News Front|
|Publication:||Household & Personal Products Industry|
|Date:||Aug 1, 2017|
|Previous Article:||Go East, young man... make that Southeast!|
|Next Article:||Bounce powder illuminator in golden bronze.|